HURA Valuation
TuHURA Biosciences Inc
$
4.200
- Overview
- Forecast
- Valuation
HURA Relative Valuation
HURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HURA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
12.06
P/B
Median3y
-109.66
Median5y
-109.66
-8.06
FCF Yield
Median3y
-9.21
Median5y
-9.21
Competitors Valuation Multiple
The average P/S ratio for HURA's competitors is 3.51, providing a benchmark for relative valuation. TuHURA Biosciences Inc Corp (HURA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
MNTK
Montauk Renewables Inc
2.240
USD
+1.82%
AUNA
Auna SA
6.910
USD
-0.86%
CSV
Carriage Services Inc
39.770
USD
+0.45%
AMPS
Altus Power Inc
4.990
USD
-0.20%
CAPR
Capricor Therapeutics Inc
13.150
USD
-5.33%
EU
enCore Energy Corp
1.420
USD
+9.23%
LPRO
Open Lending Corp
1.040
USD
+2.97%
INV
Innventure Inc
4.300
USD
-1.60%
DXYZ
Destiny Tech100 Inc
31.900
USD
+4.90%
MOFG
Midwestone Financial Group Inc (IOWA)
28.420
USD
+2.08%
FAQ
Is TuHURA Biosciences Inc (HURA) currently overvalued or undervalued?
TuHURA Biosciences Inc (HURA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of TuHURA Biosciences Inc (HURA) is between to according to relative valuation methord.
What is TuHURA Biosciences Inc (HURA) fair value?
How does HURA's valuation metrics compare to the industry average?
What is the current P/B ratio for TuHURA Biosciences Inc (HURA) as of Apr 24 2025?
What is the current FCF Yield for TuHURA Biosciences Inc (HURA) as of Apr 24 2025?
What is the current Forward P/E ratio for TuHURA Biosciences Inc (HURA) as of Apr 24 2025?